| Regulatory T-cells in autoimmune diseases: challenges, controversies and—yet—unanswered questions CR Grant, R Liberal, G Mieli-Vergani, D Vergani, MS Longhi Autoimmunity reviews 14 (2), 105-116, 2015 | 351 | 2015 |
| Autoimmune hepatitis: a comprehensive review R Liberal, CR Grant, G Mieli-Vergani, D Vergani Journal of autoimmunity 41, 126-139, 2013 | 253 | 2013 |
| COVID‐19 and liver disease—what we know on 1st May 2020 I Garrido, R Liberal, G Macedo Alimentary pharmacology & therapeutics 52 (2), 267-275, 2020 | 211 | 2020 |
| Dysfunctional CD39POS regulatory T cells and aberrant control of T‐helper type 17 cells in autoimmune hepatitis CR Grant, R Liberal, BS Holder, J Cardone, Y Ma, SC Robson, ... Hepatology 59 (3), 1007-1015, 2014 | 205 | 2014 |
| Pathogenesis of autoimmune hepatitis R Liberal, MS Longhi, G Mieli-Vergani, D Vergani Best practice & research Clinical gastroenterology 25 (6), 653-664, 2011 | 179 | 2011 |
| The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin‐9/tim‐3 pathway R Liberal, CR Grant, BS Holder, Y Ma, G Mieli‐Vergani, D Vergani, ... Hepatology 56 (2), 677-686, 2012 | 161 | 2012 |
| Diagnostic criteria of autoimmune hepatitis R Liberal, CR Grant, MS Longhi, G Mieli-Vergani, D Vergani Autoimmunity reviews 13 (4-5), 435-440, 2014 | 140 | 2014 |
| Clinical significance of autoantibodies in autoimmune hepatitis R Liberal, G Mieli-Vergani, D Vergani Journal of autoimmunity 46, 17-24, 2013 | 137 | 2013 |
| Update on autoimmune hepatitis R Liberal, D Vergani, G Mieli-Vergani Journal of clinical and translational hepatology 3 (1), 42, 2015 | 134 | 2015 |
| Autoimmune hepatitis: contrasts and comparisons in children and adults–a comprehensive review A Floreani, R Liberal, D Vergani, G Mieli-Vergani Journal of autoimmunity 46, 7-16, 2013 | 134 | 2013 |
| Cutting edge issues in autoimmune hepatitis R Liberal, EL Krawitt, JM Vierling, MP Manns, G Mieli-Vergani, D Vergani Journal of autoimmunity 75, 6-19, 2016 | 129 | 2016 |
| Inhibition of interleukin-17 promotes differentiation of CD25–cells into stable T regulatory cells in patients with autoimmune hepatitis MS Longhi, R Liberal, B Holder, SC Robson, Y Ma, G Mieli–Vergani, ... Gastroenterology 142 (7), 1526-1535. e6, 2012 | 114 | 2012 |
| Liver transplantation and autoimmune liver diseases R Liberal, Y Zen, G Mieli‐Vergani, D Vergani Liver Transplantation 19 (10), 1065-1077, 2013 | 108 | 2013 |
| Liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the Pi* ZZ mutation K Hamesch, M Mandorfer, VM Pereira, LS Moeller, M Pons, GE Dolman, ... Gastroenterology 157 (3), 705-719. e18, 2019 | 103 | 2019 |
| In autoimmune hepatitis type 1 or the autoimmune hepatitis–sclerosing cholangitis variant defective regulatory T‐cell responsiveness to IL‐2 results in low IL‐10 production and … R Liberal, CR Grant, BS Holder, J Cardone, M Martinez‐Llordella, Y Ma, ... Hepatology 62 (3), 863-875, 2015 | 103 | 2015 |
| Expert clinical management of autoimmune hepatitis in the real world R Liberal, YS de Boer, RJ Andrade, G Bouma, GN Dalekos, A Floreani, ... Alimentary pharmacology & therapeutics 45 (5), 723-732, 2017 | 98 | 2017 |
| Cirrhosis and autoimmune liver disease: current understanding R Liberal, CR Grant World journal of hepatology 8 (28), 1157, 2016 | 96 | 2016 |
| Regulatory T cells: mechanisms of suppression and impairment in autoimmune liver disease R Liberal, CR Grant, MS Longhi, G Mieli‐Vergani, D Vergani IUBMB life 67 (2), 88-97, 2015 | 91 | 2015 |
| Autoimmune hepatitis after liver transplantation R Liberal, MS Longhi, CR Grant, G Mieli–Vergani, D Vergani Clinical Gastroenterology and Hepatology 10 (4), 346-353, 2012 | 90 | 2012 |
| Autoimmune hepatitis after COVID-19 vaccine–more than a coincidence I Garrido, S Lopes, MS Simões, R Liberal, J Lopes, F Carneiro, G Macedo Journal of autoimmunity 125, 102741, 2021 | 86 | 2021 |
